Our data also demonstrated that aberrant RIPK1 kinase activation is a key effector driving myocardial apoptosis and necroptosis in vivo, which underlies cardiac remodeling and heart failure induced by TAB2 deficiency. This evidence concerns the gene RIPK1 and heart failure.